Aliskiren

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

8 Suppliers, 4 USDMF, 3 EU WC, 3 NDC API, 4 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

22 Dossiers, 20 FDA Orange Book, 2 Europe

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 22 BASF, 16 Kerry, 10 Microlex e.U, 10 Roquette, 10 Corel Pharma Chem, 9 Sigachi Industries, 8 Gangwal Chemicals, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Seppic, 6 Lonza Capsugel, 5 Gangwal Healthcare, 5 Boai NKY Pharmaceuticals Ltd, 5 Ideal Cures Pvt Ltd, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Actylis, 3 Pharmatrans-Sanaq, 3 Kima Chemical, 2 Ulanqab Kema New Material, 2 Vasa Pharmachem, 2 Nomisma Healthcare, 2 DFE Pharma, 2 Prachin Chemical, 2 Seqens, 2 The Dow Chemical Company, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Qualicaps, 1 DKSH, 1 Aeon Procare, 1 SPI Pharma, 1 Finar, 1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 22 Direct Compression, 21 Disintegrants & Superdisintegrants, 18 Thickeners and Stabilizers, 17 Granulation, 14 Solubilizers, 13 Lubricants & Glidants, 8 Film Formers & Plasticizers, 8 Co-Processed Excipients, 7 Topical, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Parenteral, 3 Emulsifying Agents, 2 Coloring Agents, 2 Rheology Modifiers

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions, 2 Finished Drug Prices

MARKET PLACE

1 APIs, 1 DOSSIERS // FDF

PATENTS

14 US Patents, 2 Health Canada Patents

DIGITAL CONTENT

13 News

13 News

Latest U.S. Prescription Data for Drugs containing Aliskiren under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Aliskiren

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

8 Suppliers

4 USDMF

3 EU WC

3 NDC API

4 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

22 Dossiers

20 FDA Orange Book

2 Europe

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE

TABLET;ORAL - EQ 300MG BASE

TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

22 BASF

16 Kerry

10 Microlex e.U

10 Roquette

10 Corel Pharma Chem

9 Sigachi Industries

8 Gangwal Chemicals

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Seppic

6 Lonza Capsugel

5 Gangwal Healthcare

5 Boai NKY Pharmaceuticals Ltd

5 Ideal Cures Pvt Ltd

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Actylis

3 Pharmatrans-Sanaq

3 Kima Chemical

2 Ulanqab Kema New Material

2 Vasa Pharmachem

2 Nomisma Healthcare

2 DFE Pharma

2 Prachin Chemical

2 Seqens

2 The Dow Chemical Company

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Qualicaps

1 DKSH

1 Aeon Procare

1 SPI Pharma

1 Finar

1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives

32 Fillers, Diluents & Binders

28 Controlled & Modified Release

22 Direct Compression

21 Disintegrants & Superdisintegrants

18 Thickeners and Stabilizers

17 Granulation

14 Solubilizers

13 Lubricants & Glidants

8 Film Formers & Plasticizers

8 Co-Processed Excipients

7 Topical

6 Chewable & Orodispersible Aids

5 Empty Capsules

4 Vegetarian Capsules

4 API Stability Enhancers

4 Taste Masking

4 Parenteral

TABLET;ORAL - EQ 150MG BASE;12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 150MG BASE;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 300MG BASE;12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 300MG BASE;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons